clomipramine has been researched along with Depression, Involutional in 54 studies
Clomipramine: A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine.
clomipramine : A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias.
Depression, Involutional: Form of depression in those MIDDLE AGE with feelings of ANXIETY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mefloquine (Lariam) is the drug of choice as malaria prophylaxis for travel to chloroquine-resistant areas." | 7.77 | [Mood disorder after malaria prophylaxis with mefloquine (two case reports)]. ( Abilkacem, L; Laffinti, A; Oueriagli Nabih, F; Touhami, M, 2011) |
| "Mefloquine (Lariam) is the drug of choice as malaria prophylaxis for travel to chloroquine-resistant areas." | 3.77 | [Mood disorder after malaria prophylaxis with mefloquine (two case reports)]. ( Abilkacem, L; Laffinti, A; Oueriagli Nabih, F; Touhami, M, 2011) |
| "Aripiprazole was added at the fixed dose of 5mg/day and clinical status as well as clomipramine plasma levels were monitored before and after 4, 8, and 24 weeks of combined treatment." | 2.77 | Aripiprazole augmentation strategy in clomipramine-resistant depressive patients: an open preliminary study. ( Catapano, F; Esposito, G; Fabrazzo, M; Maj, M; Monteleone, P; Perris, F, 2012) |
| "From a clinical point of view, orthostatic hypotension is a significant side effect during antidepressant treatment, particularly in the case of tricyclic antidepressants (TCAs)." | 2.71 | Orthostatic side effects of clomipramine and moclobemide during treatment for depression. ( Stage, KB, 2005) |
| "Major depressive disorder is one of the most common mental disorders in children and adolescents." | 2.53 | Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. ( Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X, 2016) |
| " Pharmacokinetic and pharmacogenetic analyses may improve drug therapy." | 1.46 | The combination of pharmacogenetic and pharmacokinetic analyses to optimize clomipramine dosing in major depression: a case report. ( Altamura, CA; Antoniazzi, S; Bernardi, FF; Cattaneo, D; Cheli, S; Cigliobianco, M; Clementi, E; Falvella, FS; Paoli, RA; Tatulli, A, 2017) |
| "Treatment with clomipramine alone allowed five patients to achieve sustained remission (MADRS < or = 8), while three patients were responders (MADRS decrease > or = 50%) and three patients were partial responders (MADRS decrease > 25%)." | 1.35 | Is there a place for tricyclic antidepressants and subsequent augmentation strategies in obtaining remission for patients with treatment resistant depression? ( Aubry, JM; Bertschy, G; Bondolfi, G; Gervasoni, N; Gex-Fabry, M, 2009) |
| "Clomipramine was increased to 60 mg/day, and her symptoms subsided." | 1.35 | Symptoms of delusion: the effects of discontinuation of low-dose venlafaxine. ( Kodaka, F; Koga, M; Miyata, H; Nakayama, K, 2009) |
| "Psychiatrists treated major depressive disorder in advanced cancer patients on the basis of the algorithm." | 1.35 | Clinical experience of the use of a pharmacological treatment algorithm for major depressive disorder in patients with advanced cancer. ( Akechi, T; Akizuki, N; Ito, T; Nakano, T; Okamura, M; Shimizu, K; Uchitomi, Y, 2008) |
| " TDM and pharmacogenetic tests are useful tools to improve pharmacotherapy by preventing dose-dependent adverse drug events, optimizing dosage during long-term treatment and identifying ultrarapid metabolizers and malcompliance." | 1.33 | [Therapeutic drug monitoring: A pharmacotherapeutic tool in psychiatry]. ( Etzensberger, M; Jaquenoud Sirot, E; Stephan, PL, 2006) |
| "Drug treatment with clomipramine and, to a lesser extent, with selective serotonin reuptake inhibitors was associated with hypomanic switches in OCD-bipolar patients, especially in those not concomitantly treated with mood stabilizers." | 1.31 | Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome. ( Akiskal, HS; Frare, F; Hantouche, E; Perugi, G; Toni, C; Travierso, MC, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (3.70) | 18.7374 |
| 1990's | 3 (5.56) | 18.2507 |
| 2000's | 33 (61.11) | 29.6817 |
| 2010's | 15 (27.78) | 24.3611 |
| 2020's | 1 (1.85) | 2.80 |
| Authors | Studies |
|---|---|
| Joas, E | 1 |
| Jonsson, L | 1 |
| Viktorin, A | 1 |
| Smedler, E | 1 |
| Pålsson, E | 1 |
| Goodwin, GM | 1 |
| Landén, M | 1 |
| Molina-Jímenez, T | 1 |
| Landa-Cadena, L | 1 |
| Bonilla-Jaime, H | 1 |
| Buoli, M | 2 |
| Rovera, C | 1 |
| Pozzoli, SM | 1 |
| Fiorentini, A | 1 |
| Cremaschi, L | 1 |
| Caldiroli, A | 1 |
| Altamura, AC | 2 |
| Fortinguerra, S | 1 |
| Buriani, A | 1 |
| Sorrenti, V | 1 |
| Lenzi, M | 1 |
| Giusti, P | 1 |
| Berm, EJJ | 1 |
| Paardekooper, J | 1 |
| Brummel-Mulder, E | 1 |
| Hak, E | 1 |
| Wilffert, B | 1 |
| Maring, JG | 1 |
| Arco, L | 1 |
| Cipriani, A | 1 |
| Zhou, X | 1 |
| Del Giovane, C | 1 |
| Hetrick, SE | 1 |
| Qin, B | 1 |
| Whittington, C | 1 |
| Coghill, D | 1 |
| Zhang, Y | 1 |
| Hazell, P | 1 |
| Leucht, S | 1 |
| Cuijpers, P | 1 |
| Pu, J | 1 |
| Cohen, D | 1 |
| Ravindran, AV | 1 |
| Liu, Y | 1 |
| Michael, KD | 1 |
| Yang, L | 1 |
| Liu, L | 1 |
| Xie, P | 1 |
| Antoniazzi, S | 1 |
| Tatulli, A | 1 |
| Falvella, FS | 1 |
| Cigliobianco, M | 1 |
| Paoli, RA | 1 |
| Cattaneo, D | 1 |
| Cheli, S | 1 |
| Bernardi, FF | 1 |
| Clementi, E | 1 |
| Altamura, CA | 1 |
| Dell'Osso, B | 1 |
| Zanoni, S | 1 |
| Mundo, E | 1 |
| Rucker, J | 1 |
| Cook, M | 1 |
| Cupello, A | 1 |
| Bandini, F | 1 |
| Albano, C | 1 |
| Favale, E | 1 |
| Marchese, R | 1 |
| Scarrone, S | 1 |
| Trompetto, C | 1 |
| Kundermann, B | 2 |
| Strate, P | 2 |
| Hemmeter-Spernal, J | 2 |
| Huber, MT | 2 |
| Krieg, JC | 2 |
| Lautenbacher, S | 2 |
| Gervasoni, N | 1 |
| Aubry, JM | 1 |
| Gex-Fabry, M | 1 |
| Bertschy, G | 1 |
| Bondolfi, G | 1 |
| Cordes, J | 1 |
| Larisch, R | 2 |
| Henning, U | 2 |
| Thünker, J | 1 |
| Werner, C | 1 |
| Orozco, G | 1 |
| Mayoral, F | 1 |
| Rivas, F | 1 |
| Auburger, G | 1 |
| Tosch, M | 2 |
| Rietschel, M | 1 |
| Gaebel, W | 2 |
| Müller, HW | 1 |
| Klimke, A | 2 |
| Carroll, BJ | 1 |
| Gebhardt, S | 1 |
| Koga, M | 1 |
| Kodaka, F | 1 |
| Miyata, H | 1 |
| Nakayama, K | 1 |
| Pitychoutis, PM | 1 |
| Griva, E | 1 |
| Ioannou, K | 1 |
| Tsitsilonis, OE | 1 |
| Papadopoulou-Daifoti, Z | 1 |
| Quilty, LC | 1 |
| Godfrey, KM | 1 |
| Kennedy, SH | 1 |
| Bagby, RM | 1 |
| Mihara, K | 1 |
| Nakamura, A | 1 |
| Kuba, T | 1 |
| Yakushi, T | 1 |
| Hotta, H | 1 |
| Kojima, M | 1 |
| Kondo, T | 1 |
| Minelli, A | 1 |
| Bortolomasi, M | 1 |
| Scassellati, C | 1 |
| Salvoro, B | 1 |
| Avesani, M | 1 |
| Manganotti, P | 1 |
| Fabrazzo, M | 1 |
| Perris, F | 1 |
| Monteleone, P | 1 |
| Esposito, G | 1 |
| Catapano, F | 1 |
| Maj, M | 1 |
| Oueriagli Nabih, F | 1 |
| Touhami, M | 1 |
| Laffinti, A | 1 |
| Abilkacem, L | 1 |
| Bech, P | 1 |
| Stage, KB | 3 |
| Larsen, JK | 1 |
| Vestergaard, P | 1 |
| Gram, LF | 1 |
| Komorowski, M | 1 |
| Huston, JP | 1 |
| Klingenhegel, I | 1 |
| Paulat, J | 1 |
| Sackers, J | 1 |
| Topic, B | 1 |
| Kovács, Z | 1 |
| Czurkó, A | 1 |
| Kékesi, KA | 1 |
| Juhász, G | 1 |
| Markianos, M | 2 |
| Hatzimanolis, J | 2 |
| Lykouras, L | 2 |
| Januel, D | 1 |
| Massot, O | 1 |
| Poirier, MF | 1 |
| Olié, JP | 1 |
| Fillion, G | 1 |
| van der Hart, MG | 1 |
| Czéh, B | 1 |
| de Biurrun, G | 1 |
| Michaelis, T | 1 |
| Watanabe, T | 1 |
| Natt, O | 1 |
| Frahm, J | 1 |
| Fuchs, E | 1 |
| Porter, RJ | 1 |
| Mulder, RT | 1 |
| Joyce, PR | 1 |
| Perugi, G | 1 |
| Toni, C | 1 |
| Frare, F | 1 |
| Travierso, MC | 1 |
| Hantouche, E | 1 |
| Akiskal, HS | 1 |
| Hamacher, K | 1 |
| Estalji, S | 1 |
| Hohlfeld, T | 1 |
| Vosberg, H | 1 |
| Coenen, HH | 1 |
| Müller-Gärtner, HW | 1 |
| Yamada, K | 1 |
| Yagi, G | 1 |
| Kanba, S | 1 |
| Fountoulakis, KN | 1 |
| Iacovides, A | 1 |
| St Kaprinis, G | 1 |
| Chistyakov, AV | 1 |
| Kaplan, B | 1 |
| Rubichek, O | 1 |
| Kreinin, I | 1 |
| Koren, D | 1 |
| Feinsod, M | 1 |
| Klein, E | 1 |
| Holmes, DT | 1 |
| Long, P | 1 |
| Frohlich, J | 1 |
| Loughhead, AM | 1 |
| Stowe, ZN | 1 |
| Newport, DJ | 1 |
| Ritchie, JC | 1 |
| DeVane, CL | 1 |
| Owens, MJ | 1 |
| Stephan, PL | 2 |
| Etzensberger, M | 1 |
| Jaquenoud Sirot, E | 2 |
| Mueller, B | 1 |
| Eap, CB | 1 |
| Baumann, P | 1 |
| Łojko, D | 1 |
| Rybakowski, JK | 1 |
| Okamura, M | 1 |
| Akizuki, N | 1 |
| Nakano, T | 1 |
| Shimizu, K | 1 |
| Ito, T | 1 |
| Akechi, T | 1 |
| Uchitomi, Y | 1 |
| Marchesi, C | 1 |
| Tonna, M | 1 |
| Maggini, C | 1 |
| Carvalho, LA | 1 |
| Juruena, MF | 1 |
| Papadopoulos, AS | 1 |
| Poon, L | 1 |
| Kerwin, R | 1 |
| Cleare, AJ | 1 |
| Pariante, CM | 1 |
| Pérez, V | 1 |
| Bel, N | 1 |
| Celada, P | 1 |
| Ortiz, J | 1 |
| Alvarez, E | 1 |
| Artigas, F | 1 |
| Ogura, A | 1 |
| Morinobu, S | 1 |
| Kawakatsu, S | 1 |
| Totsuka, S | 1 |
| Komatani, A | 1 |
| Montgomery, SA | 1 |
| Judge, R | 1 |
| Golden, RN | 1 |
| Heine, AD | 1 |
| Ekstrom, RD | 1 |
| Bebchuk, JM | 1 |
| Leatherman, ME | 1 |
| Garbutt, JC | 1 |
| Burnand, Y | 1 |
| Andreoli, A | 1 |
| Kolatte, E | 1 |
| Venturini, A | 1 |
| Rosset, N | 1 |
| Kragh-Sørensen, PB | 1 |
| Strian, F | 1 |
| Albert, W | 1 |
| Klicpera, C | 1 |
| Singer, L | 1 |
| Finance, MF | 1 |
| Ruh, MD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD) a Multicentre Open-label Randomized Controlled Trial Protocol[NCT05814640] | Phase 1/Phase 2 | 520 participants (Anticipated) | Interventional | 2023-02-20 | Recruiting | ||
| Development and Evaluation of an Ecological Momentary Assessment (EMA) Baseline Screening System for Therapists Who Treat Youths With Depressive Symptoms[NCT04830527] | 60 participants (Actual) | Interventional | 2020-11-24 | Terminated (stopped due to The study was terminated early due to the difficulty in recruiting cases during a pandemic period.) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for clomipramine and Depression, Involutional
| Article | Year |
|---|---|
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Co | 2016 |
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Co | 2016 |
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Co | 2016 |
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Co | 2016 |
17 trials available for clomipramine and Depression, Involutional
| Article | Year |
|---|---|
Is trazodone more effective than clomipramine in major depressed outpatients? A single-blind study with intravenous and oral administration.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Antidepressive Agents; Clomipramine; | 2019 |
Intravenous augmentative citalopram versus clomipramine in partial/nonresponder depressed patients: a short-term, low dose, randomized, placebo-controlled study.
Topics: Administration, Oral; Antidepressive Agents; Citalopram; Clomipramine; Depressive Disorder, Major; D | 2008 |
Mid-term effects of serial sleep deprivation therapy implemented in cognitive-behavioral treatment on the neuroendocrine response to clomipramine in patients with major depression.
Topics: Adult; Affect; Analysis of Variance; Antidepressive Agents, Tricyclic; Behavior Therapy; Clomipramin | 2009 |
Pain sensitivity in major depression and its relationship to central serotoninergic function as reflected by the neuroendocrine response to clomipramine.
Topics: Antidepressive Agents, Tricyclic; Area Under Curve; Chi-Square Distribution; Clomipramine; Depressiv | 2009 |
Harm avoidance as a mediator of treatment response to antidepressant treatment of patients with major depression.
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder, Major; Dose-Response Rel | 2010 |
Aripiprazole augmentation strategy in clomipramine-resistant depressive patients: an open preliminary study.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Clomipramine; Dep | 2012 |
The predictive validity of atypical neurovegetative depressive symptoms identified by the first principal component in the DUAG trial of moclobemide versus clomipramine.
Topics: Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder, Major; Double-Blind Method; Fem | 2012 |
Serotonergic and dopaminergic neuroendocrine responses of male depressive patients before and after a therapeutic ECT course.
Topics: Adult; Aged; Clomipramine; Depressive Disorder, Major; Dopamine Antagonists; Electroconvulsive Thera | 2002 |
Relationship between prolactin responses to ECT and dopaminergic and serotonergic responsivity in depressed patients.
Topics: Adult; Aged; Clomipramine; Depressive Disorder, Major; Dopamine Antagonists; Electroconvulsive Thera | 2002 |
Interaction of lithium with 5-HT(1B) receptors in depressed unipolar patients treated with clomipramine and lithium versus clomipramine and placebo: preliminary results.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Adult; Antidepressive Agents; Blood Platelets; Clomi | 2002 |
Baseline prolactin and L-tryptophan availability predict response to antidepressant treatment in major depression.
Topics: Administration, Oral; Adolescent; Adult; Antidepressive Agents, Tricyclic; Biological Availability; | 2003 |
Influence of synaptic serotonin level on [18F]altanserin binding to 5HT2 receptors in man.
Topics: Adult; Antidepressive Agents, Tricyclic; Brain; Clomipramine; Depressive Disorder, Major; Drug Inter | 2003 |
Clinical efficacy of tandospirone augmentation in patients with major depressive disorder: a randomized controlled trial.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder, Maj | 2003 |
Antidepressant effects of different schedules of repetitive transcranial magnetic stimulation vs. clomipramine in patients with major depression: relationship to changes in cortical excitability.
Topics: Aged; Analysis of Variance; Antidepressive Agents; Cerebral Cortex; Clomipramine; Depressive Disorde | 2005 |
Orthostatic side effects of clomipramine and moclobemide during treatment for depression.
Topics: Adult; Aged; Antidepressive Agents; Clomipramine; Depressive Disorder, Major; Drug Administration Sc | 2005 |
Clomipramine dose-effect study in patients with depression: clinical end points and pharmacokinetics. Danish University Antidepressant Group (DUAG).
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Clomipramine; Denmark; Depressive Disorder, Major; Do | 1999 |
Psychodynamic psychotherapy and clomipramine in the treatment of major depression.
Topics: Adult; Aged; Awareness; Clomipramine; Combined Modality Therapy; Depressive Disorder, Major; Empathy | 2002 |
36 other studies available for clomipramine and Depression, Involutional
| Article | Year |
|---|---|
Effect of CYP2C19 polymorphisms on antidepressant prescription patterns and treatment emergent mania in bipolar disorder.
Topics: Amitriptyline; Antidepressive Agents; Bipolar Disorder; Clomipramine; Cytochrome P-450 CYP2C19; Cyto | 2023 |
Chronic treatment with estradiol restores depressive-like behaviors in female Wistar rats treated neonatally with clomipramine.
Topics: Animals; Animals, Newborn; Antidepressive Agents; Behavior, Animal; Clomipramine; Depressive Disorde | 2017 |
Molecular network-selected pharmacogenomics in a case of bipolar spectrum disorder.
Topics: Antidepressive Agents, Tricyclic; Bipolar Disorder; Clomipramine; Depressive Disorder, Major; Female | 2017 |
A simple dried blood spot method for therapeutic drug monitoring of the tricyclic antidepressants amitriptyline, nortriptyline, imipramine, clomipramine, and their active metabolites using LC-MS/MS.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Biotransformation; Calibration; Chromatography, Liq | 2015 |
A case study in treating chronic comorbid obsessive-compulsive disorder and depression with behavioral activation and pharmacotherapy.
Topics: Amitriptyline; Antidepressive Agents; Behavior Therapy; Chronic Disease; Clomipramine; Depressive Di | 2015 |
The combination of pharmacogenetic and pharmacokinetic analyses to optimize clomipramine dosing in major depression: a case report.
Topics: Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder, Major; Drug Monitoring; Female; | 2017 |
A case of prolonged seizure after ECT in a patient treated with clomipramine, lithium, L-tryptophan, quetiapine, and thyroxine for major depression.
Topics: Affect; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antimanic Agents; Antipsychotic Age | 2008 |
Catatonic features in major depression relieved by electroconvulsive treatment: parallel evaluation of the status of platelet serotonin transporter.
Topics: Aged; Blood Platelets; Catatonia; Clomipramine; Depressive Disorder, Major; Dose-Response Relationsh | 2008 |
Is there a place for tricyclic antidepressants and subsequent augmentation strategies in obtaining remission for patients with treatment resistant depression?
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder, Major; Drug Resistance; | 2009 |
Abnormal neuroendocrine response to clomipramine in hereditary affective psychosis.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Bipolar Disorder; Clomipramine; Depressive Disorder, | 2009 |
Clomipramine and glucocorticoid receptor function.
Topics: Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder, Major; Dexamethasone; Dose-Resp | 2009 |
Symptoms of delusion: the effects of discontinuation of low-dose venlafaxine.
Topics: Adult; Clomipramine; Cyclohexanols; Delusions; Depressive Disorder, Major; Dose-Response Relationshi | 2009 |
Chronic antidepressant treatment exerts sexually dimorphic immunomodulatory effects in an experimental model of major depression: do females lack an advantage?
Topics: Animals; Antidepressive Agents, Tricyclic; Cell Proliferation; Cells, Cultured; Chronic Disease; Clo | 2009 |
Ropinirole augmentation therapy in a case with treatment-resistant unipolar depression.
Topics: Aged; Antidepressive Agents; Clomipramine; Depressive Disorder, Major; Dopamine Agonists; Drug Thera | 2010 |
Effects of intravenous antidepressant drugs on the excitability of human motor cortex: a study with paired magnetic stimulation on depressed patients.
Topics: Antidepressive Agents, Tricyclic; Citalopram; Clomipramine; Depressive Disorder, Major; Evoked Poten | 2010 |
[Mood disorder after malaria prophylaxis with mefloquine (two case reports)].
Topics: Adult; Antimalarials; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clomipramine; Depress | 2011 |
Distance from source of reward as a marker for extinction-induced "despair": modulation by the antidepressants clomipramine and citalopram.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Citalopram; Clomipramine; Conditioning, Operan | 2012 |
Neonatal tricyclic antidepressant clomipramine treatment reduces the spike-wave discharge activity of the adult WAG/Rij rat.
Topics: Action Potentials; Age Factors; Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Choice | 2012 |
Substance P receptor antagonist and clomipramine prevent stress-induced alterations in cerebral metabolites, cytogenesis in the dentate gyrus and hippocampal volume.
Topics: Animals; Antidepressive Agents, Tricyclic; Body Weight; Brain Chemistry; Cell Division; Chronic Dise | 2002 |
Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Bipolar Disorder; C | 2002 |
Combined oral venlafaxine and intravenous clomipramine-A: successful temporary response in a patient with extremely refractory depression.
Topics: Administration, Oral; Adult; Clomipramine; Cyclohexanols; Depressive Disorder, Major; Diagnostic and | 2004 |
Dysbetalipoproteinemia and clomipramine.
Topics: Antidepressive Agents, Tricyclic; Apolipoprotein E2; Apolipoproteins E; Clomipramine; Depressive Dis | 2005 |
Placental passage of tricyclic antidepressants.
Topics: Antidepressive Agents, Tricyclic; Birth Weight; Clomipramine; Depressive Disorder, Major; Dose-Respo | 2006 |
[Therapeutic drug monitoring: A pharmacotherapeutic tool in psychiatry].
Topics: Adverse Drug Reaction Reporting Systems; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Bio | 2006 |
Adverse drug reactions following nonresponse in a depressed patient with CYP2D6 deficiency and low CYP 3A4/5 activity.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Cholelithiasis; Clomi | 2006 |
L-thyroxine augmentation of serotonergic antidepressants in female patients with refractory depression.
Topics: Adult; Bipolar Disorder; Clomipramine; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Co | 2007 |
Clinical experience of the use of a pharmacological treatment algorithm for major depressive disorder in patients with advanced cancer.
Topics: Adult; Aged; Algorithms; Alprazolam; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Benzod | 2008 |
Obsessive-compulsive disorder followed by psychotic episode in long-term ecstasy misuse.
Topics: Adolescent; Amphetamine-Related Disorders; Antidepressive Agents, Tricyclic; Antipsychotic Agents; B | 2009 |
Clomipramine in vitro reduces glucocorticoid receptor function in healthy subjects but not in patients with major depression.
Topics: Adult; Brain; Brain Chemistry; Cells, Cultured; Clomipramine; Depressive Disorder, Major; Dose-Respo | 2008 |
Relationship between blood serotonergic variables, melancholic traits, and response to antidepressant treatments.
Topics: Adult; Antidepressive Agents; Blood Platelets; Clomipramine; Depressive Disorder; Depressive Disorde | 1998 |
Changes in regional brain activity in major depression after successful treatment with antidepressant drugs.
Topics: Adult; Amoxapine; Antidepressive Agents, Tricyclic; Brain; Cerebral Cortex; Clomipramine; Depressive | 1998 |
Treatment of depression with associated anxiety: comparisons of tricyclic antidepressants and selective serotonin reuptake inhibitors.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Clomipramine; Depressive Disorder, Major; Fluox | 2000 |
A longitudinal study of serotonergic function in depression.
Topics: Adult; Antidepressive Agents, Tricyclic; Area Under Curve; Clomipramine; Depressive Disorder, Major; | 2002 |
Age-related adverse drug reactions to clomipramine.
Topics: Adult; Age Factors; Aged; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder, Major | 2002 |
Antidepressive treatment and mood swing patterns in endogenous depression.
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Bipolar Disorder; Clomipra | 1979 |
[Pulmonary embolisms occurring in 1 month in 3 aged women with manic-depressive psychoses. Discussion. Etiopathogenic role or psychiatric treatment].
Topics: Aged; Antidepressive Agents; Bipolar Disorder; Chlorpromazine; Clomipramine; Depressive Disorder, Ma | 1975 |